Conference abstract · 1 Sep 2015
ArticlePublished 2015
Mitochondrial Respiratory Disorders: A Perspective On Their Metabolite Biomarkers And Implications For Clinical Diagnosis And Therapeutic Intervention
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Abstract Mitochondrial respiratory disorders are incurable progressive degenerative diseases with multi-organ system manifestations. These orphan diseases are caused by mutations in the nuclear or mitochondrial genome affecting the oxidative phosphorylation (OXPHOS) system responsible for ATP synthesis. Currently, therapeutic treatments are not available to patients, resulting in significant disability and a poor prognosis. Patients exhibit a constellation of complex neurological and multisystem phenotypic symptoms. The hallmark of these diseases is their clinical heterogeneity and high variability among patients. Consequently, establishing an accurate diagnosis remains a challenging, invasive, and time-consuming process due to the limited sensitivity, specificity and reliability of the current serum biomarkers used in clinical settings. Recent mouse model-based research combined with patient studies led to the identification of fibroblast growth factor 21 (FGF-21) as a promising serum biomarker. With its high specificity and sensitivity, FGF-21 is a promising diagnostic tool for muscle-affecting mitochondrial respiratory disorders, which might be a useful first- line diagnostic tool instead of the invasive muscle biopsy currently performed in clinical settings. Discovering additional diagnostic biomarkers is critical for establishing an accurate diagnosis given the high clinical heterogeneity of these mitochondrial respiratory diseases. Ultimately, these novel biomarkers might be instrumental to monitor the progression of these diseases and the efficacy of novel therapeutic interventions.
Keywords
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 3 Oct 2024
Clinical Implications of Cardiac Biomarkers in the Diagnosis and Prognosis of Acute Coronary Syndromes
Commentary · 24 Aug 2024
Grasping Neurodegenerative Disorders: Utilizing Molecular Biomarkers for Enhanced Diagnosis
Commentary · 17 Jun 2024
Understanding Neurodegenerative Disorders: Harnessing Molecular Biomarkers for Diagnosis
Conference abstract · 1 Sep 2015
Organ-specific autoimmune disorders: Translational biomarkers to confirm the diagnosis and to predict chronification and disabling
More from this journal
The newest in Biomarkers Journal.
Article · 30 Dec 2024
The Role of Metabolomics Markers in Understanding Disease Mechanisms
Article · 30 Dec 2024
Genomic Biomarkers: Bridging the Gap between Genetics and Precision Medicine
Article · 30 Dec 2024
Cryogenic Markers: Advancing Low Temperature Science and Applications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiomarkers Journal
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Martine Uittenbogaard”
- BylineArticles whose byline prints “Anne Chiaramello”
